Thus, alendronate ligand would contribute to the accumulation of the MSNs into the bone tumour tissue, and then the well-known overexpression of cathepsine-K in those tumour environments would cleave the peptide sequence exposing the RGD motif, which would trigger the preferential uptake of the MSNs by the tumour cells. Here, CTSK is linked to neoplasm.